Atlas Trials

Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides

Clinical trial NCT01187446 · TERMINATED

Trial details

NCT number
NCT01187446
Sponsor
Stanford University
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Cutaneous LymphomaCutaneous T-cell Lymphoma
Start date
2010-12-01
Primary completion
2013-08-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.